|
Column 1 |
Column 2 |
1 |
FY19 Half year results |
Expected 27 February 2019 |
I don't expect half year results to be pretty, more focused on the progress of SAMR approval for infant formulas.
As they have just changed new formulas and increased price, sales might not look good especially in China, imo.